Evidence map›Paper›PMID 28428223›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2017

Glutamatergic Mechanisms Involved in Bladder Overactivity and Pudendal Neuromodulation in Cats.

Jamie Uy, Michelle Yu, Xuewen Jiang, Cameron Jones, Bing Shen, Jicheng Wang, James R Roppolo, William C de Groat, Changfeng Tai

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jamie UyDepartment of Urology (J.U., M.Y., X.J., C.J., B.S., J.W., C.T.), Department of Pharmacology and Chemical Biology (J.R.R., W.C.D., C.T.), and Department of Bioengineering (C.T.),University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J.).
Michelle YuDepartment of Urology (J.U., M.Y., X.J., C.J., B.S., J.W., C.T.), Department of Pharmacology and Chemical Biology (J.R.R., W.C.D., C.T.), and Department of Bioengineering (C.T.),University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J.).
Xuewen JiangDepartment of Urology (J.U., M.Y., X.J., C.J., B.S., J.W., C.T.), Department of Pharmacology and Chemical Biology (J.R.R., W.C.D., C.T.), and Department of Bioengineering (C.T.),University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J.).
Cameron JonesDepartment of Urology (J.U., M.Y., X.J., C.J., B.S., J.W., C.T.), Department of Pharmacology and Chemical Biology (J.R.R., W.C.D., C.T.), and Department of Bioengineering (C.T.),University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J.).
Bing ShenDepartment of Urology (J.U., M.Y., X.J., C.J., B.S., J.W., C.T.), Department of Pharmacology and Chemical Biology (J.R.R., W.C.D., C.T.), and Department of Bioengineering (C.T.),University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J.).
Jicheng WangDepartment of Urology (J.U., M.Y., X.J., C.J., B.S., J.W., C.T.), Department of Pharmacology and Chemical Biology (J.R.R., W.C.D., C.T.), and Department of Bioengineering (C.T.),University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J.).
James R RoppoloDepartment of Urology (J.U., M.Y., X.J., C.J., B.S., J.W., C.T.), Department of Pharmacology and Chemical Biology (J.R.R., W.C.D., C.T.), and Department of Bioengineering (C.T.),University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J.).
William C de GroatDepartment of Urology (J.U., M.Y., X.J., C.J., B.S., J.W., C.T.), Department of Pharmacology and Chemical Biology (J.R.R., W.C.D., C.T.), and Department of Bioengineering (C.T.),University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J.).
Changfeng TaiDepartment of Urology (J.U., M.Y., X.J., C.J., B.S., J.W., C.T.), Department of Pharmacology and Chemical Biology (J.R.R., W.C.D., C.T.), and Department of Bioengineering (C.T.),University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J.) cftai@pitt.edu.
University of Pittsburgh · USQilu University of Technology · CNQilu Hospital of Shandong University · CN

Funding

Parasympathetic and sympathetic mechanisms underlying bladder nociceptionR01DK111382 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKEL, JONATHAN M · 2017 to 2020
$1.4M
Neurotransmitter Receptors Involved in Neuromodulation of Bladder OveractivityR01DK102427 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TAI, CHANGFENG · 2014 to 2017
$924k
Central Sites of Action for Bladder NeuromodulationR01DK094905 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TAI, CHANGFENG · 2013 to 2016
$922k
NIDDK NIH HHS R01 DK094905NIDDK NIH HHS R01 DK102427NIDDK NIH HHS R01 DK111382
6 · The paper itself

Abstract

The involvement of ionotropic glutamate receptors in bladder overactivity and pudendal neuromodulation was determined in

Indexed as

GlutamatesAcetic AcidAnimalsCatsDizocilpine MaleateDose-Response Relationship, DrugElectric StimulationExcitatory Amino Acid AntagonistsFemaleMalePudendal NerveQuinazolinesReceptors, AMPAReceptors, N-Methyl-D-AspartateUrinary BladderUrinary Bladder, OveractiveAcetic AcidCP 465,022Dizocilpine MaleateExcitatory Amino Acid AntagonistsGlutamatesQuinazolinesReceptors, AMPAReceptors, N-Methyl-D-Aspartate

Identifiers

PMID28428223
PMCPMC5454588
OpenAlexW2606127231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.